Cardiogen — Khavinson bioregulator — cardiac muscle / cardiomyocyte
Cardiogen is a tetrapeptide bioregulator for cardiac tissue. Similar to Cortagen but specifically formulated for cardiomyocyte metabolism. Proposed to restore cardiomyocyte gene expression, enhance myocardial energy metabolism, reduce inflammatory mediators, and support post-ischemic recovery. Mechanistic overlap with Cortagen — these are related compounds from the same research group.
Overview
This page is part of Hormonaly's evidence-graded compound library. All clinical claims are linked to peer-reviewed sources via our dual-layer citation verification pipeline.
Compound Class
Khavinson bioregulator — cardiac muscle / cardiomyocyte
Mechanism of Action
Cardiogen is a tetrapeptide bioregulator for cardiac tissue. Similar to Cortagen but specifically formulated for cardiomyocyte metabolism. Proposed to restore cardiomyocyte gene expression, enhance myocardial energy metabolism, reduce inflammatory mediators, and support post-ischemic recovery. Mechanistic overlap with Cortagen — these are related compounds from the same research group.
Regulatory Status
Not FDA approved. Research peptide.
Evidence Level
Very Low — preclinical animal studies; no published RCTs. Evidence from Korkushko et al. in aging animal models.